Our Inflammation and Longevity Medicine hub and article on Inflammation, Brain Health, and Mental Wellbeing explain why inflammatory burden belongs in the cognitive-health conversation
These mechanisms have not been systematically investigated in ASD populations, and no antioxidant trials to date have reported sex-specific treatment outcomes
if finalized, large-scale 503B compounding of these drugs changes significantly - verify current status at FDA.gov before enrolling
Anyone tempted to notice that 2 mg is reassuringly close to the communitys 1.7 mg figure should notice instead that a rodent wound-chamber method is not a dose-finding study, and that the resemblance is a coincidence of scale rather than a validation
The observations here reflect clinical experience treating medical weight loss patients at New Jersey Bariatric Center since 2006
What the research actually shows Let us be direct about what the evidence supports and what it does not